Suppr超能文献

提高腺瘤检出率及每次结肠镜检查腺瘤质量指标的测量:印第安纳大学的经验

Improving measurement of the adenoma detection rate and adenoma per colonoscopy quality metric: the Indiana University experience.

作者信息

Kahi Charles J, Vemulapalli Krishna C, Johnson Cynthia S, Rex Douglas K

机构信息

Department of Medicine, Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA; Richard L. Roudebush Veterans Affairs Medical Center, Indianapolis, Indiana, USA.

Department of Medicine, Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

出版信息

Gastrointest Endosc. 2014 Mar;79(3):448-54. doi: 10.1016/j.gie.2013.10.013. Epub 2013 Nov 15.

Abstract

BACKGROUND

The adenoma detection rate (ADR) is a validated marker of colonoscopy quality. However, the optimal measurement method is unclear.

OBJECTIVE

The aims of our study were to (1) define benchmarks for the number of adenomas per screening colonoscopy (APC) quality metric; (2) study the association between ADRs for screening, surveillance, and diagnostic indications; and (3) explore the association of the screening ADR with an overall ADR inclusive of all colonoscopy indications.

DESIGN

Retrospective study.

SETTING

University hospital and associated ambulatory surgery center endoscopy units.

PATIENTS

Patients aged ≥50 years who underwent colonoscopy for screening, surveillance, or diagnostic indications by 20 endoscopists between January 1, 1999 and April 30, 2012.

INTERVENTION

Colonoscopy.

MAIN OUTCOME MEASUREMENTS

ADR, APC for screening, surveillance, and diagnostic indications.

RESULTS

A total of 21,766 colonoscopies were included. The indication was screening in 7434 (34.2%), surveillance in 8338 (38.3%), and diagnostic in 5994 (27.5%). The screening ADRs and APCs were significantly correlated (R = 0.91; P < .0001). For men, an ADR of 25% corresponded to an APC of 0.46 (95% confidence interval [CI], 0.35-0.57); for women, an ADR of 15% corresponded to an APC of 0.20 (95% CI, 0.13-0.27). Overall, the ADR stratified by colonoscopy indication was highest for surveillance, followed by screening, then diagnostic. For men, a screening ADR of 25% corresponded to a surveillance ADR of 31.9% (95% CI, 24.8%-38.9%); for women, an ADR of 15% corresponded to a surveillance ADR of 24.3% (95% CI, 18.3%-30.5%). The corresponding diagnostic ADRs were 17.0% (95% CI, 12.4%-21.6%) and 15.4% (95% CI, 11.5%-19.3%), respectively. There was significant correlation between screening ADR and an overall ADR inclusive of all colonoscopy indications.

LIMITATIONS

External generalizability, retrospective design.

CONCLUSION

We propose minimum screening APC detection benchmarks of 0.50 for men and 0.20 for women. ADRs for screening, surveillance, and diagnostic colonoscopy are correlated and can be used to derive a simplified overall ADR inclusive of all colonoscopy indications.

摘要

背景

腺瘤检出率(ADR)是已得到验证的结肠镜检查质量指标。然而,最佳测量方法尚不清楚。

目的

我们研究的目的是:(1)确定每次筛查结肠镜检查腺瘤数量(APC)质量指标的基准;(2)研究筛查、监测和诊断指征的ADR之间的关联;(3)探讨筛查ADR与包含所有结肠镜检查指征的总体ADR之间的关联。

设计

回顾性研究。

地点

大学医院及相关门诊手术中心内镜科室。

患者

1999年1月1日至2012年4月30日期间,20名内镜医师为年龄≥50岁的患者进行筛查、监测或诊断性结肠镜检查。

干预措施

结肠镜检查。

主要观察指标

ADR、筛查、监测和诊断指征的APC。

结果

共纳入21766例结肠镜检查。检查指征为筛查的有7434例(34.2%),监测的有8338例(38.3%),诊断的有5994例(27.5%)。筛查ADR与APC显著相关(R = 0.91;P <.0001)。对于男性,ADR为25%时对应的APC为0.46(95%置信区间[CI],0.35 - 0.57);对于女性,ADR为15%时对应的APC为0.20(95%CI,0.13 - 0.27)。总体而言,按结肠镜检查指征分层的ADR在监测时最高,其次是筛查,然后是诊断。对于男性,筛查ADR为25%时对应的监测ADR为31.9%(95%CI,24.8% - 38.9%);对于女性,ADR为15%时对应的监测ADR为24.3%(95%CI,18.3% - 30.5%)。相应的诊断ADR分别为17.0%(95%CI,12.4% - 21.6%)和15.4%(95%CI,11.5% - 19.3%)。筛查ADR与包含所有结肠镜检查指征的总体ADR之间存在显著相关性。

局限性

外部可推广性、回顾性设计。

结论

我们建议男性的最低筛查APC检测基准为0.50,女性为0.20。筛查、监测和诊断性结肠镜检查的ADR相关,可用于得出包含所有结肠镜检查指征的简化总体ADR。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验